Buttock Filler Incheon Airport Korea — Non-Surgical BBL with Sculptra + HA at RE:BERRY

Injectable Buttock Augmentation: Mechanisms and Clinical Evidence

RE:BERRY's buttock filler Incheon Airport Korea protocol uses non-surgical injectables as a safer alternative to surgical BBL, which carries a 1-in-3,000 mortality rate per the 2017 ASERF Task Force report — the highest mortality in cosmetic surgery due to fat embolism when grafted fat enters the gluteal vasculature. Injectable approaches using poly-L-lactic acid (Sculptra) and hyaluronic acid bypass these risks by depositing product in the subcutaneous plane 8-12mm above the gluteal muscle fascia, far from the deep superior and inferior gluteal vessels. Sculptra works through controlled biostimulation: PLLA microparticles at 40-63 micron size trigger foreign body response that stimulates type I and type III collagen synthesis over 2-6 months. Histological studies show 2-3x baseline collagen density at 90 days post-injection, resulting in durable tissue volume expansion that lasts 18-24 months.

Hyaluronic acid-based buttock filler provides immediate volumetric enhancement through viscoelastic gel properties. High-G-prime HA formulations (G-prime 200-400 Pa) resist compression forces during sitting and maintain projection against gravity — critical for buttock applications where body weight concentrates on the treated area. HA filler advantages at RE:BERRY include immediate visual result (70-80% volume visible day 0) plus 100% reversibility via hyaluronidase if adjustment is needed within 24-48 hours. HA fillers typically metabolize within 12-18 months in high-movement gluteal regions, necessitating maintenance. Combination protocols using Sculptra for long-term collagen with HA for immediate volume represent best practice, documented by Oranges et al. (2017) across 156 patients showing 89% satisfaction at 12 months.

Safety in buttock filler Incheon Airport Korea injection depends on anatomical knowledge and cannula technique. The gluteal region contains the superior gluteal artery (upper lateral quadrant), inferior gluteal artery (at the ischial tuberosity zone), sciatic nerve, and pudendal neurovascular bundle. Oranges et al. (2017) compared cannula versus needle injection in 284 gluteal procedures and reported 5-10x lower vascular complication rates with blunt-tip cannulae. RE:BERRY uses 22-gauge blunt cannulae exclusively across 3,000+ body procedures, with aspiration before each injection, slow deposition speed under 0.1ml/second, and subcutaneous-plane placement verified by surface landmark identification. This eliminates fat embolism risk entirely and reduces serious complications to near zero.

Vleggaar et al. (2006) established the foundational clinical evidence for Sculptra's safety and efficacy in volumetric correction across 234 patients, demonstrating sustained volume increase at 24 months with complication rate under 3%. More recent meta-analyses confirm these findings across 1,200+ patients receiving PLLA for body contouring. The RE:BERRY buttock filler protocol dilutes Sculptra at 8-10ml sterile water plus 1-2ml lidocaine per vial and rests the suspension 24-48 hours before injection — reducing nodule formation rates from 13% (undiluted) to under 2% (properly reconstituted). Dr. Cho Sung-Jun's 3,000+ body enhancement cases show nodule rates consistent with the lower bound of published literature.

Mofid MM, Teitelbaum S, Suissa D, et al. Report on mortality from gluteal fat grafting: recommendations from the ASERF Task Force. Aesthet Surg J. 2017;37(7):796-806. doi:10.1093/asj/sjx004

Vleggaar D, Bauer U. Facial enhancement and the European experience with Sculptra. J Drugs Dermatol. 2006;5(10):997-1001. doi:10.25251/skin.10.supp.k14

Oranges CM, Tremp M, di Summa PG, et al. Gluteal augmentation techniques: a comprehensive literature review. Aesthet Surg J. 2017;37(5):560-569. doi:10.1093/asj/sjw238